by admin | Feb 2, 2023 | Events
2 February 2023 | Organisers: GENDRO and CIOMS
GENDRO and CIOMS jointly convened a meeting with key stakeholders, including the World Medical Association, Council of Europe, World Health Organization, representatives from research ethics committees, research institutions, and the pharmaceutical industry. The focus was on the crucial role of Research Ethics Committees (RECs) in addressing gender bias in research with human participants, using the SAGER guidelines as a valuable tool. CIOMS’ Secretary General Dr. Lembit Rägo initiated a dialogue on the role of RECs in strengthening sex and gender considerations in health research. GENDRO’s President, Dr. Shirin Heidari, underscored the concern of inadequate incorporation of sex and gender considerations in research and credited the success of the SAGER guidelines in raising awareness and improving reporting. Emphasizing the responsibility of every gatekeeper in the research ecosystem, including RECs, Dr. Heidari stressed the need for proper integration of sex and gender considerations throughout health research.
Dr. Abha Saxena, an independent bioethicist, presented findings from a scoping review conducted as part of GENDRO’s working group on gender and research ethics, revealing a lack of evidence on sufficient attention to sex and gender dimensions in the work of RECs.
The meeting facilitated consensus-building on the importance of a unified approach among all stakeholders in the research ecosystem to enhance the inclusion and meaningful consideration of sex and gender in research. The meeting concluded with proposed actions and a collaborative path forward, committed to by GENDRO and CIOMS.
Read the full report here.
by Gendro | Jun 17, 2021 | Events
The panel was chaired by Shirin Heidari from GENDRO, and the presenters included Tracey Goodman from WHO and Lavanya Vijayasingham from UNU-IIGH. Jean Munro from GAVI moderated the discussion, while the panelists included Apoorva Mandavilli, a journalist from The New York Times, Prof Noni MacDonald from Dalhousie University, Canada, and Prof Saad Omer from Yale University, USA. Amidst the unprecedented scale and speed of vaccine research and development, and the mammoth task of ‘leaving no one behind’ in the global deployment of COVID-19 vaccines, there was a need to ensure that critical sex- and gender dimensions were not ‘deprioritized’ in evidence generation, policy decision-making, and communication initiatives.
Stronger considerations of sex and gender factors in these areas could contribute to better science and innovation, prevent avoidable harm, build public understanding and trust in a timely manner, and ultimately improve immunization coverage. Some key areas that required attention and action included the persistent oversight of sex and gender dimensions in clinical trials and other vaccine-related research, nuanced analysis of post-market surveillance and pharmacovigilance data that could inform sex-based differences in the frequency or severity of adverse events, the lack of data in specific populations such as pregnant and lactating women in the initial phases of vaccine roll-out in some countries, sex and gender dimensions of vaccine confidence, acceptability, and uptake, and transparent and accurate science reporting to clearly communicate the relevant sex and gender dimensions to the lay audience.
Learn more here:
Presentation 1: Critical sex and gender considerations for equitable research, development and delivery of COVID-19 vaccines
Presentation 2: SDG3 GAP Gender working group /UNU-IIGH Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment
Event recording : https://www.youtube.com/watch?v=825vOFeqbQ4&ab_channel=UNU-IIGH
by Gendro | Jun 15, 2021 | Events
This webinar offered an overview of the purpose of Sex and Gender Based Analysis (SGBA), its application to public health, and provided an overview of some key examples from a forthcoming book on SBGA in Public Health (https://www.springer.com/us/book/9783…) edited by Jacqueline Gahagan, Professor of Health.
Promotion came from Dalhousie University and Mary Bryson, Senior Associate Dean, Administration, Faculty Affairs & Innovation and Professor, Department of Language and Literacy Education, Faculty of Education, University of British Columbia.
Session speakes included Jacqueline Gahagan, PhD, Full Professor, Health Promotion Division, Faculty of Health, Dalhousie University Shirin Heidari, PhD, Founder of GENDRO Sizulu Moyo, PhD, Research Director, Human Sciences Research Council of South Africa Cara Tannenbaum, MD, Scientific Director of the Canadian Institutes of Health Research, Institute of Gender and Health.
Learn more here: https://www.cpha.ca/sites/default/fil… https://www.cpha.ca/sites/default/files/uploads/webinars/2021-06-15-sgba_webinar_deck.pdf
Event recording : https://www.youtube.com/watch?v=h8HCRnlLlUY&ab_channel=CanadianPublicHealthAssociation
